Tamra E. Werbowetski-Ogilvie

Tamra E. Werbowetski-Ogilvie

Auto-generated profile, based on publicly available information

Tamra E. Werbowetski-Ogilvie

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, United States of America

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2007 in Nature
Verified
Journal Article
Closed access
SBSean C. Bendall
Sean C. Bendall
MSMorag H. Stewart
Morag H. Stewart
PMPablo Menendez
Pablo Menendez
DGDustin George
Dustin George
KVKausalia Vijayaragavan
Kausalia Vijayaragavan
MBMickie Bhatia
Mickie Bhatia

4 January 2009 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TWTamra E Werbowetski-Ogilvie
Tamra E Werbowetski-Ogilvie
MBMarc Bossé
Marc Bossé
MSMorag Stewart
Morag Stewart
ASAngelique Schnerch
Angelique Schnerch
VRVeronica Ramos-Mejia
Veronica Ramos-Mejia
MBMickie Bhatia
Mickie Bhatia

1 May 2004 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
DDDanny Del Duca
Danny Del Duca
TWTamra Werbowetski
Tamra Werbowetski
RMRolando F. Del Maestro
Rolando F. Del Maestro

28 January 2008 in BMC Cancer
Verified
Journal Article
Open access
PDF file
AHAlexander Hamm
Alexander Hamm
JVJuergen Veeck
Juergen Veeck
NBNuran Bektas
Nuran Bektas
PWPeter J Wild
Peter J Wild
Arndt HartmannArndt Hartmann
Arndt Hartmann
Edgar DahlEdgar Dahl
Edgar Dahl
Background: The inter-alpha-trypsin inhibitors (ITI) are a family of plasma protease inhibitors, assembled from a light chain – bikunin, encoded byAMBP– and five homologous heavy chains (encoded byITIH1,ITIH2,ITIH3,ITIH4, andITIH5), contributing to extracellular matrix stability by covalent linkage to hyaluronan. So far, ITIH molecules have been shown to play a particularly important role in inflammation and carcinogenesis.Methods: We systematically investigated differential gene expression of theITIHgene family, as well asAMBPand the interacting partnerTNFAIP6in 13 different human tumor entities (of breast, endometrium, ovary, cervix, stomach, small intestine, colon, rectum, lung, thyroid, prostate, kidney, and pancreas) using cDNA dot blot analysis (Cancer Profiling Array, CPA), semiquantitative RT-PCR and immunohistochemistry.Results: We found thatITIHgenes are clearly downregulated in multiple human solid tumors, including breast, colon and lung cancer. Thus,ITIHgenes may represent a family of putative tumor suppressor genes that should be analyzed in greater detail in the future. For an initial detailed analysis we choseITIH2expression in human breast cancer. Loss ofITIH2expression in 70% of cases (n = 50, CPA) could be confirmed by real-time PCR in an additional set of breast cancers (n = 36). Next we studied ITIH2 expression on the protein level by analyzing a comprehensive tissue micro array including 185 invasive breast cancer specimens. We found a strong correlation (p < 0.001) between ITIH2 expression and estrogen receptor (ER) expression indicating that ER may be involved in the regulation of this ECM molecule.Conclusion: Altogether, this is the first systematic analysis on the differential expression ofITIHgenes in human cancer, showing frequent downregulation that may be associated with initiation and/or progression of these malignancies.

21 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
LHLiam Hendrikse
Liam Hendrikse
PHParthiv Haldipur
Parthiv Haldipur
OSOlivier Saulnier
Olivier Saulnier
JMJake Millman
Jake Millman
ASAlexandria H. Sjoboen
Alexandria H. Sjoboen
MTMichael D. Taylor
Michael D. Taylor

24 April 2006 in Oncogene
Verified
Journal Article
Open access
PDF file
TWT E Werbowetski-Ogilvie
T E Werbowetski-Ogilvie
MSM Seyed Sadr
M Seyed Sadr
NJN Jabado
N Jabado
AAA Angers-Loustau
A Angers-Loustau
NAN Y R Agar
N Y R Agar
RMR F Del Maestro
R F Del Maestro
Invasion of brain tumor cells has made primary malignant brain neoplasms among the most recalcitrant to therapeutic strategies. We tested whether the secreted protein Slit2, which guides the projection of axons and developing neurons, could modulate brain tumor cell invasion. Slit2 inhibited the invasion of medulloblastoma cells in a variety of in vitro models. The effect of Slit2 was inhibited by the Robo ectodomain. Time-lapse videomicroscopy indicated that Slit2 reduced medulloblastoma invasion rate without affecting cell direction or proliferation. Both medulloblastoma and glioma tumors express Robo1 and Slit2, but only medulloblastoma invasion is inhibited by recombinant Slit2 protein. Downregulation of activated Cdc42 may contribute to this differential response. Our findings reinforce the concept that neurodevelopmental cues such as Slit2 may provide insights into brain tumor invasion.